MRCP2-3035
A 45-year-old woman with myasthenia gravis is admitted to the hospital due to pneumonia and a flare-up of her myasthenia symptoms. She is given antibiotics, pyridostigmine, and methylprednisolone, and her condition begins to improve. Additionally, she receives IV magnesium replacement to address hypomagnesemia. However, the following day, her symptoms suddenly worsen, and she experiences significant weakness upon exertion and new dysphagia, necessitating the insertion of a nasogastric (NG) tube. Which medication administered by the medical team is the most likely culprit?